GAMMA Investing LLC boosted its position in Lemonade, Inc. (NYSE:LMND - Free Report) by 35,901.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 19,801 shares of the company's stock after purchasing an additional 19,746 shares during the quarter. GAMMA Investing LLC's holdings in Lemonade were worth $630,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Jones Financial Companies Lllp lifted its position in Lemonade by 6.8% in the 4th quarter. Jones Financial Companies Lllp now owns 5,870 shares of the company's stock valued at $215,000 after purchasing an additional 375 shares during the last quarter. Summit Investment Advisors Inc. raised its position in shares of Lemonade by 8.4% during the 4th quarter. Summit Investment Advisors Inc. now owns 5,463 shares of the company's stock worth $200,000 after buying an additional 423 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Lemonade by 0.3% during the 4th quarter. Bank of New York Mellon Corp now owns 151,186 shares of the company's stock worth $5,545,000 after buying an additional 442 shares in the last quarter. Quarry LP raised its position in shares of Lemonade by 300.4% during the 4th quarter. Quarry LP now owns 933 shares of the company's stock worth $34,000 after buying an additional 700 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its position in shares of Lemonade by 116.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 1,596 shares of the company's stock worth $59,000 after buying an additional 860 shares in the last quarter. 80.30% of the stock is currently owned by institutional investors.
Lemonade Stock Performance
Shares of LMND traded up $3.74 during mid-day trading on Friday, hitting $44.24. The company's stock had a trading volume of 4,178,642 shares, compared to its average volume of 2,047,949. The firm has a 50-day moving average price of $32.57 and a 200 day moving average price of $34.48. Lemonade, Inc. has a fifty-two week low of $14.90 and a fifty-two week high of $53.85.
Lemonade (NYSE:LMND - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.84) by ($0.02). Lemonade had a negative return on equity of 36.72% and a negative net margin of 38.90%. The business's revenue was up 27.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.67) earnings per share. Equities research analysts anticipate that Lemonade, Inc. will post -3.03 EPS for the current fiscal year.
Analyst Ratings Changes
A number of analysts have commented on LMND shares. Piper Sandler dropped their price target on shares of Lemonade from $44.00 to $34.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Morgan Stanley downgraded shares of Lemonade from an "equal weight" rating to an "underweight" rating and dropped their price target for the stock from $35.00 to $24.00 in a research report on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods dropped their price target on shares of Lemonade from $25.00 to $22.00 and set an "underperform" rating on the stock in a research report on Tuesday, April 22nd. Four research analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $28.17.
Check Out Our Latest Stock Analysis on LMND
Insider Transactions at Lemonade
In other Lemonade news, insider John Sheldon Peters sold 1,494 shares of Lemonade stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $35.25, for a total value of $52,663.50. Following the completion of the sale, the insider now directly owns 106,115 shares in the company, valued at $3,740,553.75. The trade was a 1.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Softbank Group Capital Ltd sold 42,160 shares of Lemonade stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $37.22, for a total transaction of $1,569,195.20. Following the completion of the sale, the insider now owns 10,452,476 shares of the company's stock, valued at $389,041,156.72. This trade represents a 0.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,744,737 shares of company stock valued at $87,411,365 over the last ninety days. Corporate insiders own 14.70% of the company's stock.
Lemonade Company Profile
(
Free Report)
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Further Reading

Before you consider Lemonade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.
While Lemonade currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.